TITLE

Bone Disorders in Human Immunodeficiency Virus Infection

AUTHOR(S)
Glesby, Marshall J.
PUB. DATE
September 2003
SOURCE
Clinical Infectious Diseases;9/1/2003 Supplement 2, Vol. 37, pS91
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Osteopenia, osteoporosis, and osteonecrosis are the most significant bone disorders affecting patients with human immunodeficiency virus (HIV) infection. HIV-infected patients receiving potent antiretroviral therapy have a high prevalence of reduced bone mineral density (BMD). However, patients not receiving antiretrovirals also have a higher than expected prevalence of reduced BMD, which suggests that HIV itself may be a contributing factor, mediated by immune activation and cytokines. The risk of fractures remains undefined in this population, and no data exist on interventions to increase BMD and prevent fractures. Osteonecrosis has been reported in HIV-infected patients since 1990, and its incidence appears to be increasing. Available data suggest that corticosteroid use and other risk factors contribute significantly to its pathogenesis.Controlled studies have not supported the contention that protease inhibitors increase the risk of osteonecrosis. An improved understanding of the pathogenesis of these bone disorders should result in better preventative and therapeutic measures.
ACCESSION #
10854778

 

Related Articles

  • Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients. Gazzola, Lidia; Bellistri, Giusi Maria; Tincati, Camilla; Ierardi, Valentina; Savoldi, Alessia; del Dole, Angelo; Tagliabue, Luca; Marchetti, Antonella d'Arminio Monforte1 and Giulia // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background: HIV-infected patients display an increased and early incidence of osteopenia/osteoporosis. We investigated whether bone metabolism disorders in HIV-infected patients are related to immune hyperactivation and premature immune senescence. Methods: Bone mineral density (BMD) was...

  • Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan. Negredo, Eugenia; Bonjoch, Anna; Gómez-Mateu, Moisés; Estany, Carla; Puig, Jordi; Perez-Alvarez, Nuria; Rosales, Joaquin; di Gregorio, Silvana; Rio, Luis del; Gómez, Guadalupe; Clotet, Bonaventura // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Background: Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objective was to assess how often a dual-energy x-ray absorptiometry (DXA) scan should be performed by assessing time of progression to osteopenia/osteoporosis. Methods: All DXA scans...

  • Increased prevalence, progression to osteoporosis observed in patients with HIV.  // Infectious Disease News;Dec2010, Vol. 23 Issue 12, p29 

    The article reports on a study which revealed an increased prevalence and progression to osteoporosis in patients with HIV.

  • Abnormalities in the bone mineral metabolism in HIV-infected patients. García Aparicio, A.; Muñoz Fernández, S.; González, J.; Arribas, J.; Peña, J.; Vázquez, J.; Martínez, M.; Coya, J.; Martín Mola, E. // Clinical Rheumatology;Aug2006, Vol. 25 Issue 4, p537 

    Objective: To evaluate bone mineral metabolism in HIV infected and asymptomatic patients receiving highly active antiretroviral therapy (HAART) containing protease inhibitors (PI) and naïve patients. Methods: We studied 30 asymptomatic HIV infected male patients, 13 in the naive group and 17...

  • Bone health in HIV infection. Pollock, Emily; Klotsas, Angelos-Emmanouil; Compston, Juliet; Gkrania-Klotsas, Effrossyni // British Medical Bulletin;Dec2009, Vol. 92 Issue 1, p123 

    Introduction: Osteoporosis is among the chronic problems emerging as the human immunodeficiency virus (HIV)-positive population ages.

  • HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV Infection. Del Carpio-Cano, Fabiola E.; DeLa Cadena, Raul A.; Sawaya, Bassel E. // Journal of Osteoporosis;2013, p1 

    Increased life expectancy and the need for long-termantiretroviral therapy have brought newchallenges to the clinical management of HIV-infected individuals. The prevalence of osteoporosis and fractures is increased in HIV-infected patients; thus optimal strategies for risk management and...

  • RESEARCH BRIEFS.  // GP: General Practitioner;3/28/2008, p7 

    The article offers news briefs related to medical research. A study conducted by South African researchers reveals that people infected with a mutated HIV strain have better survival rates. British researchers stress in their study that occupational exposure to milk powder inhalation doubles the...

  • A case of march fracture in a patient with osteoporosis on long-term HAART. Forsyth, Sophie F.; Gazzard, Brian G.; Nelson, Mark R. // International Journal of STD & AIDS;Sep2002, Vol. 13 Issue 9, p645 

    The article discusses the consideration of osteoporosis as a diagnosis in patients with HIV infection. A 50-year-old man, who was given a highly active antiretroviral therapy, was gathered with data on the nature and effects of the treatment. Results indicate that HIV-infected patients are prone...

  • High prevalence of radiological vertebral fractures in HIV-infected males. Torti, Carlo; Mazziotti, Gherardo; Soldini, Pier; Focà, Emanuele; Maroldi, Roberto; Gotti, Daria; Carosi, Giampiero; Giustina, Andrea // Endocrine (1355008X);Jun2012, Vol. 41 Issue 3, p512 

    Age-related co-morbidities including osteoporosis are relevant in patients responding to combination antiretroviral therapy (cART). Vertebral fractures are common osteoporotic fractures and their diagnosis is useful for managing at-risk individuals. However, there are few data from HIV-infected...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics